Biotech Pharma Q2 2025 AIDriven Innovation MA Activity and Policy Headwinds Shape Sector Landscape OFSSH Q1 2026 Earnings Stellar EPS Surge Defies Estimates as Note Price Holds Steady Shreya Acquisition Group Files Form 13G with SEC